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ABSTRACT 
Objectives of the study include answer to the research question or to the hypothesis framed. 
Present study was conducted to evaluate the therapeutic effect of Shilajithu loha rasayana in 
reducing the affliction of Basti marma in patients with Prameha/diabetic nephropathy, also to 
evaluate the therapeutic effect of Shilajithu loha rasayana in reducing the blood sugar level in 
patients suffering from affliction of Basti marma in Prameha/diabetic nephropathy. Design: 
Study Type: Interventional, Estimated enrolment: 30 participants, Allocation: Non-Randomized, 
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Primary 
Purpose: Treatment, Masking: Open Label. Participants: From October 2019 to January 2020, 
30 patients of affliction of Basthi marma in Prameha/ diabetic nephropathy having symptoms of 
diabetic nephropathy (microalbuminuria, reduced eGFR, raised cystatin-c) with a minimum of 
5yrs history of diabetes are taken up for the study. Intervention: Kosta shodhana on day 1: 
20ml of Eranda taila added with equal amount of Shunthi kashaya is orally administered during 
early morning in empty stomach. Day 2 to 22: Shilajithu loha rasayana is orally administered 
half an hour before breakfast, in a dose of 12g with warm water. Patient was advised diabetic 
diet and to do brisk walking/jogging or light exercise for 45 minutes daily during the course of 
treatment. Results: Shilajithu loha rasayana was successful in improving renal functions by 
increasing the glomerular filtration rate and reducing cystatin-c in patients also was successful 
in reducing fasting blood sugar and symptoms of Prameha which was justified statistically with 
p value <0.001. Conclusion: Shilajithu loha rasayana was successful in increasing the renal 
function and reducing symptoms of Prameha. 
KEYWORDS: Prameha, Shilajithu loha rasayana, Basthi marma abhigata. 
INTRODUCTION 
 Indian culture and diversity has given lot of 
valuable treatise which throws light on various 
aspects for the human population to follow. All the 
ancient medical texts not only give importance on 
knowledge of disease and its treatment but also a 
detailed explanation on rules and regulation to lead a 
healthy life. In the present era of modernization 
people have deviated from traditional lifestyle to the 
modernized way of leaving. Though this change gave 
luxurious living in the society but along with this, the 
level of mental stress and unhealthy diet and 
activities also increased. 
The modern way of living is characterized by 
intake of diet that are rich in fats and high calorie or 
the combination of both, along with lack of physical 
activities. This unique change has increased the 
incidence of disease in the society and are collectively 
called as Santarpana vikara or metabolic syndrome in 
conventional system[1]. Prameha is one such disorder 
that is explained in texts which can be matched with 
the symptomatology of diabetes mellitus. The disease 
is considered as one among Mahagada because it 
affects each and every cell in the body. The incidence 
of diabetes has been increasing with the sedentary 
life style in the society. 
Prameha is a disorder known to mankind 
since ages, it is caused by the vitiation of morbid 
Dosha effecting the 10 body elements[2]. It’s an 
established fact that with the change in lifestyle and 
sedentary lifestyle there is a rapid increase in the 
incidence of Prameha in India. India is one among the 
top 3rd countries with maximum cases of diabetes 
along with china and United States[3]. Prameha when 
not treated well can lead to various serious 
complications that may even prove fatal. One among 
such complications is Basthi marma abhigata. Basthi 
is the seat for all Mootravaha srotas vikara and 
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Prameha for a certain period if not controlled can 
lead to affliction of Basthi marma[4].  
The same can be matched with diabetic 
nephropathy. Prolonged uncontrolled blood sugar 
can damage nephrons leading to nephropathy. 
Diabetic nephropathy can present with micro-
albuminuria initially and at a long run accounts for 
major cause for death in end stage renal disease. 
Early diagnosis and early treatment along with 
proper glycaemic control is the key to success in such 
cases[5]. Shodhana and Shamana are the two folds of 
treatment that is common to all diseases. There are 
certain groups of drug that acts on Prameha by 
controlling the glycaemic control on other hand 
certain group of drug acts on Mootravaha srotas and 
prevents nephron damage. Apart from these a special 
group of drugs that acts on Prameha as well as 
Mootravaha srotas is mentioned in texts.  
Nearly 300 works done related to the efficacy 
of herbal and herbomineral drugs in Prameha, many 
more on effect of Shodhana and Shamana in Prameha. 
Few more on the efficacy of folklore medicine.  Also 
the total number of studies on Mootravaha srotas is 
very less. Rasayana is one unique way of treating 
chronic illness and the study on Rasayana in Prameha 
did not cross single digit and this area has a huge 
scope for further studies. 
MATERIALS AND METHODOLOGY 
Objectives of the Study 
This study entitled An open clinical study 
evaluating the effect of Shilajithu loha rasayana on 
affliction of Basti marma (diabetic nephropathy) in 
patients with Prameha is aimed to fulfill the following 
objectives 
• Evaluating the therapeutic effect of Shilajithu loha 
Rasayana in reducing the affliction of Basti marma 
in patients with Prameha/diabetic nephropathy  
• Evaluating the therapeutic effect of Shilajithu loha 
rasayana in reducing the blood sugar level in 
patients suffering from affliction of Basti marma in 
Prameha/ diabetic nephropathy. 
Source of Data 
Subjects with affliction of Basti marma due to 
Prameha/diabetic nephropathy will be selected for 
the study from OPD & IPD of Sri Dharmasthala 
Manjunatheshwara Ayurveda Hospital, Udupi. The 
Shilajithu loha rasayana required for the study will be 
procured from the Sri Dharmasthala 
Manjunatheshwara Ayurveda pharmacy, Udupi.  
Method of Collection of Data 
A minimum of 30 Patients suffering from 
affliction of Basti marma in due to Prameha/ diabetic 
nephropathy will be screened under strict diagnostic, 
inclusion and exclusion criteria and will be selected 
for the study. These patients are invited to 
participate in the study after signing the informed 
consent and then registered for the clinical trial. As 
per the intervention protocol these subjects will be 
given Shilajithu loha rasayana for the stipulated 
period. Patients are advised to undergo standard 
dietary management and therapeutic exercise for 
diabetes. The primary and secondary outcome 
measures are assessed before and after the 
medication. 
Diagnostic Criteria[6] 
 Clinical diagnosis of Prameha based on history of 
premonitory and cardinal symptoms. 
 Diagnosis of type 2 diabetes mellitus fulfilling at 
least 1 of the following criteria. 
 Subjects taking on anti-diabetics and / or insulin 
 Documented evidence in the medical history of 
fasting glucose >/= 180mg /dl. 
 Documented evidence in the medical history of 
HbA1c >/=6.5%. 
 Diagnosis of diabetic nephropathy fulfilling at least 
1 of the following criteria 
 Urinary albumin-to-creatinine ratio (UACR) of 




 Subjects with Type 2 diabetes mellitus and 
diabetic nephropathy. 
 Well controlled blood sugar level (HbA1c≤7.5%) 
at screening. 
 Serum creatinine ≤ 1.4 mg/dL at Screening. 
 Sitting blood pressure of <=170/100 mm Hg at 
screening.  
 Ages Eligible for Study: 40 Years to 70 Years.  
 Males and non pregnant non lactating females.  
 Able and willing to give written informed consent.  
Exclusion Criteria 
 Subjects with type 1 diabetes mellitus.  
 Diabetes mellitus resulting from pancreatic 
disorder.  
 Secondary diabetes mellitus (Cushing's syndrome, 
steroidogenic diabetes).  
 Subjects who have history of acute kidney injury.  
 History of non-diabetic renal disease, including 
renal artery stenosis.  
 Patients who have undergone haemodialysis at 
any time.  
 severe uncontrolled hypertension (sitting diastolic 
blood pressure > 115 and/or sitting systolic blood 
pressure> 220 mm Hg).  
 Persons addicted to alcohol.  
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Parameters and its  Gradations 
Kshudha (Appetite)  
0 –normal limits  
1- 2 main meals, light breakfast 2-3 / day  
2- 2 main meals, light breakfast 3-5 / day  
3- 2 main meals, light breakfast > 5 / day  
Atitrishna  
Quantity of water intake polydipsia  
0- Intake of water 5-7 times / 24 hours with 
quantity 1.5-2.5 litres / 24 hours  
1- Intake of water 7-9 times / 24 hours with 
quantity 2.5-3.0 litres / 24 hours  
2- Intake of water 9-11 times / 24 hours with 
quantity 3.0 – 3.5 litres / 24 hours  
3- Intake of water >11 times / 24 hours with 
quantity >3.5 litres / 24 hours  
 Kara-pada-tala-daha/ supti (Neuropathy)  
0- No daha  
1- Kara pada tala daha is not continuous  
2- Kara pada tala daha continuous but not severe  
3- Kara pada tala daha continuous and severe  
Daurbalya (Debility)  
0- Can do routine exercise / work  
1- Can do moderate exercise with difficulty  
2- Can do mild exercise only, with difficulty  
3- Cannot too mild exercise  
Prabhoota mootrata  
Quantity of urine (in litre)  
0- 1.5 to 2.00  
1- 2.00 to 2.50  
2- 2.50 to 3.00  
3- 3.00 onwards  
Frequency of Urine  
0 - 3 To 6 Times per Day, Rarely At Night  
1 - 6 to 9 Times per Day, 0-2 Times Per Night  
2 – 9 To 12 Times Per Day, 2-4 Times per Night  
3- More Than 12 Times per Day, More Than 4 
Times per Night  
Avila Mootrata  
It will be measured using turbidimetry analysis 
method 
Design of the study 
Study Type: Interventional. 
Estimated enrolment: 30 participants.  
Allocation: Non-Randomized. 
Endpoint Classification: Efficacy Study. 
Intervention Model: Single Group Assignment.  
Primary Purpose: Treatment.  





Kosta shodhana day 1:20ml of Eranda taila 
with equal quantity of Shunthi kasaya administered 
orally during early morning in empty stomach. 
Day 2-day 22:  Shilajithu loha rasayana is orally 
administered half an hour before breakfast in a dose 
of 12 grams with hot water. 
Duration of study:  22 days of intervention and 30 
days of follow up period. 
Follow up: 30 Days after treatment. 
Assessment Criteria 
Primary Outcome Measures 
 Change from baseline in urinary Cystatin C at 
completion of course of Shilajithu loha rasayana    
(Time Frame: day 1 and day 22)  
 Change from baseline in eGFR Calculated Using 
Cystatin C at completion of course of Shilajithu 
loha rasayana (Time Frame: day 1 and day 22)  
 Change from baseline in Fasting blood sugar (FBS) 
at completion of course of Shilajithu loha rasayana 
(Time Frame: day 1 and day 22)  
 Change from baseline in Glycosylated 
haemoglobin (A1C) at completion of course of 
Shilajithu loha rasayana (Time Frame: day 1 and 
day 22)   
Secondary outcome measure: 
 Change from baseline in Urine albumin-to-
creatinine ratio (UACR) at completion of course of 
Shilajithu loha rasayana (Time Frame: day 1 and 
day 22) 
 Change from baseline in Systolic Blood Pressure 
and Diastolic Blood Pressure) at completion of 
course of Shilajithu loha rasayana (Time Frame: 
day 1 and day 22) 
 Change from baseline in the severity score of 
clinical symptoms of Prameha at completion of   
course of Shilajithu loha rasayana (Time Frame: 
day 1 and day 22) 
Subjective parameters: signs and symptoms of 
Prameha 
1. Kshuda (appetite) 
2. Atitrishna 
3. Kara-pada-daha/ supti (neuropathy) 
4. Dourbalya (debility) 
5. Prabhuta mootrata 
6. Frequency of Urine 
7. Avila Mootrata 
OBSERVATION 
In the present study total 30 patients of 
Prameha were registered and allocated into single 
group. The observations of the study were made 
under following headings:  Demographic description, 
Observations on personal history, Observation on 
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family history, Observation on general examination, 
Observation on Dashavida pariksha. 
Among 30 patients, maximum number of 
patients, 47% were between the age group of 61- 70, 
followed by 46% of patients between 51-60 and 7% 
of patients between 41-50 age group. 59% were 
males and 41% were females. 90% of patients were 
Hindu, 7% of patients were Christians and 3% of 
patients were Muslim. 28 patients in the study were 
married and 2 patients were widow. 44% patients 
completed graduation, 30% patients completed 
primary education, 13% patients completed high 
school and 13% patients were illiterate. 44% were 
having desk work as their profession, 30% were 
homemakers, and 13% had their occupation as 
labour 13% had their occupation as field work. Total 
of 60% patients belonged to middle class and 40% of 
patients belonged to lower middle class. There were 
no patients belonging to upper class, upper middle 
class, and lower class. 80% of patients adopted mixed 
diet and 20% of patient had vegetarian diet. 70% 
patients had sound sleep were as 30% of patients had 
disturbed sleep. 64% of patients had Madhyama 
Kosta, 25% with Krura Kosta and 11% with Mridu 
Kosta.  60% of the patients had a family history of 
diabetes. And 40% did not have history of diabetes in 
family members. 67% of patients were on oral 
hypoglycaemic agents, 20% patients on Ayurvedic 
medications, and 13% patients on insulin. 
RESULT 
30 patients in the age group of 40-70years 
having the symptoms of Prameha/ diabetes mellitus, 
and diagnosed to have Basthi marma abhigata due to 
Prameha / diabetic nephropathy with the symptoms 
like polydipsia, polyuria, unexplained weight loss, 
history of plasma glucose more than 180mg/dl and 
on screening raised cystatin-c and eGFR more than 
30 less than 90 and HBA1C less than 7.5% was taken 
for the study and after willing to give a written 
consent was included for the study. The study was 
designed to evaluate the parameters related to 
diabetes and diabetic nephropathy and cardinal 
symptoms of Prameha before and after the treatment. 
With this background patient was administered 20ml 
of Eranda taila along with 20ml of Shunthi kashaya 
on day 1 for Kosta shodhana. From day 2 to day 22 
patients were administered Shilajithu loha rasayana 
12g in capsule form (each capsule of 1gm each) 
empty stomach half an hour before breakfast with 
warm water. 
The mean score of cystatin-c before the 
treatment was 1.196 (±0.0181) and after 21 days of 
intervention it reduced to 1.037 (±0.0181) recording 
an improvement of 13.294% on laboratory values, 
which was statistically significant with p=<0.001. 
This proves that Shilajithu loha rasayana was very 
much effective in reducing cystatin-c in patients. 
Table 1: Effect of Treatment on Cystatin-c 
Criteria  Time Mean ± SD ±SE Differenc
e in mean 
% 
improvement 
Paired T Test 
t value P value 
1.530 -  
0.708 
BT 1.196 0.0989 0.0181 0.159 13.294% t = 9.210 P = <0.001 
AT 1.037 0.135 0.0181 
The mean score of estimated glomerular filtration rate before the treatment was 62.912 (±1.500) and 
that after 21 days of intervention was increased to 89.193 (±0.954) recording improvement of 42.1% on 
laboratory values, which was statistically significant with p=<0.001. This again proves that the formulation 
Shilajithu loha rasayana was very much effective in increasing the estimated glomerular filtration rate thus 
improving the kidney function. 
Table 2: Effect of Treatment on Estimated Glomerular Filtration Rate 
Criteria 
(Range) 




Paired t test 
t value P value 
120-231 
 
BT 174.167 25.093 4.581 32.233  18.50% 15.515 P = <0.001 
 AT 141.933 19.138 3.494 
The mean score of fasting blood sugar before the treatment was 174.167 (±4.581) and was reduced to 
141.933 (±3.494) after treatment with a recording of 18.50% on laboratory values, which was statistically 
significant with p=<0.001. Thus proving the efficacy of Shilajithu loha rasayana in reducing the plasma sugar 
levels.  
Table 3: Effect of Treatment on Fasting Blood Sugar 
Criteria 
(Range) 




Paired t test 
t value P value 
120-231 
 




15.515 P= <0.001 
 AT 141.933 19.138 3.494 
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The mean score of glycosylated haemoglobin (HBA1C) before the treatment was 7.313 (±0.0893) and 
that after intervention was 7.163 (±0.0780) with a recording of 2.05% in laboratory values, which was 
statistically significant with p=<0.001. This proves on a whole that Shilajithu rasayana has a very good anti-
diabetic property. 
Table 4: Effect of Treatment on Glycosylated Haemoglobin 
Criteria 
(Range) 




Paired t test 
t value P value 
7.9-6.4 
 




6.289 P = <0.001 
 AT 7.163 0.427 0.0780 
The mean score of urine albumin to creatinine ratio before the treatment was 85.186 (±4.100) and that 
after the intervention was reduced to 64.541 (±3.556) recording 24.23% of improvement in laboratory values, 
which was statistically significant with p=<0.001. This proved that Shilajithu loha rasayana was effective in 
improving the renal function. 
Table 5: Effect of Treatment on Urine Albumin to Creatinine Ratio 
Criteria 
(Range) 




Paired t test 
t value P value 
7.9-6.4 
 
BT 85.186 22.456 4.100 20.645 24.23% 
 
15.921 P = <0.001 
 AT 64.541 19.478 3.556 
The mean score of systolic blood pressure before the treatment was 140.333 (±1.477) and after the 
intervention was reduced to 132.667 (±1.433) with 5.46% of improvement in the reading, which was 
statistically significant with p=<0.001. This proved that Shilajithu loha rasayana by improving the renal 
function proved efficacious in reducing the systolic blood pressure. 
Table 6: Effect of Treatment on Systolic Blood Pressure 
Criteria 
(Range) 




Paired t test 
t value P value 
150-120 
 




4.678 P = <0.001 
 AT 132.667 7.849 1.433 
The mean score of grading of Prabootha mootrata before the treatment was 1.367 (±0.112) and was 
reduced to 0.667 (±0.0875) after the intervention with a recording of 51.02% of improvement, which was 
statistically significant with p=<0.001. The efficacy of Shilajithu loha rasayana in reducing the cardinal 
symptom of Prameha was proved beneficial. 
Table 7: Effect of Treatment on Prabhoota mootrata. 
Criteria 
(Range) 





z value P value 
AT 0.667 0.479 0.0875 
  
The mean score of grading of Avila mootrata before the treatment was 1.067 (±0.135) and was reduced 
to 0.367 (±0.102) after the treatment with 65.60% of improvement in the scoring which was statistically 
significant with p=<0.001. Hence Shilajithu loha rasayana was successful in reducing Avila mootrata in patients 
with Prameha. 
Table 8: Effect of Treatment on Avila mootrata 
Criteria 
(Range) 





z value P value 
4-0 
 






P = <0.001 
AT 0.367 0.556 0.102 
The mean score of grading of Kshuda before the treatment was 0.767 (±0.0785) and was reduced to 
0.400 (±0.0910) with 47.84% of improvement in the symptom which was statistically significant with p=0.017. 
Hence Shilajithu loha rasayana was successful in reducing Kshuda in patients with Prameha. 
Table 9: Effect of Treatment on Kshuda 
Criteria 
(Range) 





z value P value 
4-0 
 






P =  0.017 
 AT 0.400 0.498 0.0910 
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The mean score of grading of Dourbalya before the treatment was 1.467 (±0.0926) and was reduced to 
0.800 (±0.0743) after the treatment with a marked improvement of 45.4% in the symptom which was 
statistically significant with p=<0.001. Hence Shilajithu loha rasayana was successful in reducing Dourbalya in 
patients with Prameha. 
Table 10: Effect of Treatment on Dourbalya 
Criteria 
(Range) 





z value P value 
4-0 BT 1.467 0.507 0.0926 0.667 
 
45.4% 4.264 P = <0.001 
AT 0.800 0.407 0.0743 
The mean score of grading of Kara pada daha before the treatment was 1.433 (±0.177) and was 
reduced to 0.800 (±0.121) after the treatment with the marked improvement of 44.17% in the symptom, which 
was statistically significant with p=<0.001. Hence Shilajithu loha rasayana was successful in reducing Kara pada 
daha in patients with Prameha. 
Table 11: Effect of Treatment on Kara pada daha 
Criteria 
(Range) 





z value P value 
4-0 
 






P = <0.001 
AT 0.800 0.664 0.121 
The mean score of grading of Trishna before the treatment was 0.533 (±0.0926) and was reduced to 
0.200 (±0.0743) after the treatment with the marked improvement of 62.4% in symptom, which was 
statistically significant with p=0.002. Hence Shilajithu loha rasayana was successful in reducing Trishna in 
patients with Prameha. 
Table 12: Effect of Treatment on Trishna 
Criteria 
(Range) 





z value P value 
4-0 
 






P = 0.002 
 AT 0.200 0.407 0.0743 
The mean score of grading of frequency of urine before the treatment was 0.467 (±0.0926) and after the 
intervention was reduced to 0.167 (±0.0692) recording improvement of 64.3% in the symptom, which was 
statistically significant with p=0.004. Hence Shilajithu loha rasayana was successful in reducing frequency of 
urine in patients with Prameha. 
Table 13: Effect of treatment on frequency of urine 
Criteria 
(range) 





Z value P value 
4-0 BT 0.467 0.507 0.0926 0.3 64.3% 3.000 P = 0.004 
 AT 0.167 0.379 0.0692     
DISCUSSION 
Excessive consumption of fatty food with lack 
of physical exercise leads to group of disease that 
includes Prameha, Hridroga, and Gulma, Vataraktha 
and Shonitha dusti. These diseases are collectively 
known as Santarpana janya vikara. And in 
conventional system these are put under the heading 
of metabolic disorders. Out of these metabolic 
disorders Prameha is one among the dreadful disease 
that has been causing problem to mankind. Diabetes 
is parallel term that is mentioned in conventional 
system. Developing countries like India the disease 
Prameha is a real challenge in preventing and 
controlling it. According to recent studies the 
incidence of diabetes in developing counties like 
India has rapidly increased due to sedentary lifestyle 
and lack of physical activities. 
The combination of morbid Medas and Kapha 
travels all over the body vitiating other two Dosha 
and 10 body elements with either of two 
consequences. The Kapha and Medas vitiates Mamsa 
dhatu leading to Prameha pidaka or the Kapha and 
Medas vitiates Kleda leading vitiation of fluid in the 
body. This vitiated fluid along with the other vitiated 
elements gets lodged in Basthi. The vitiated Kleda is 
then converted into Mutra and is thrown out of the 
body. Initially Prameha starts with predominance of 
Kapha dosha and then ends with the predominance of 
Vata dosha. Though Prameha is Medas srotas vikara 
the symptoms and signs exhibited by the disease is 
related to Mootravaha srotas. This is because the seat 
that the disease takes place is Basthi. Change in 
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quality and quantity are the symptoms of individual 
types of Prameha.  
When this pathogenesis continues for a 
certain time this damages Basthi marma and results 
in various complication. Text states when there is 
severe damage to Basthi person will die immediately 
but when there is minimal damage that will lead to a 
serious illness with this base there will be damage 
that will lead to symptoms like Shotha in the body 
and this stage of disease is called as Basthi marma 
Abhighata due to Prameha. There are two lines of 
thoughts, first group states that the morbid Kapha 
and Medas vitiates the Sharira kleda, lodges in Basthi 
produces Prameha. When untreated properly this 
will further aggravate to the predominance of Pitta 
and then end up with Vata dosha. In a long run when 
this is left untreated this will lead to affliction of 
Basthi marma and produce symptoms like Shotha. So 
the first school claims Basthi marma abhigata as a 
complication of Vataja prameha. The second school 
claims that the vitiated Kapha medas and other 
elements gets lodged in Basthi and on a long run this 
itself will afflict the Basthi marma leading to Basthi 
marma abhighata. Though both the explanation holds 
a valid justification it’s difficult to identify which 
pathogenesis is more accurate. 
On the contrary the disease Prameha can be 
matched with diabetes mellitus in conventional 
system. Pancreas is a very important organ in the 
body that is responsible for digestion and glucose 
homeostasis. This endocrine gland secrets insulin 
and this is associated with sugar metabolism and 
carbohydrate metabolism. Absolute or relative 
deficiency is the main cause for diabetes which is 
characterised by abnormalities of carbohydrate, 
protein and fat metabolism. Diagnosis of diabetes 
mellitus is mainly based on plasma glucose level. 
Polyuria, polydipsia, polyphagia are the main 
symptoms that are seen. Uncontrolled hyper-
glycaemia for a certain time acts as a risk factor for 
all major organ damage and thus can lead to serious 
complications. Among those complications renal 
damage due to diabetes is quite more common. This 
complication remains asymptomatic at the initial 
stage, and when it is symptomatic it will be in end 
stage.  
Diabetic nephropathy or diabetic kidney 
disease is one of the major microvascular 
complications. And it accounts for major cause for 
deaths in end stage renal disease. The disease 
develops as a result of nephron damage due to 
prolonged hyperglycaemia. Due to this there will be 
expansion of mesangium leading to a permanent 
nodule formation named Kimmelstel-Wilson nodules. 
The disease is initially diagnosed by chance or on 
screening for complications of diabetes. It initially 
starts with microalbuminuria. Diagnosis of the 
disease at this stage is by checking cystatin-c, 
estimated glomerular filtration rate and urine 
albumin to creatinine ratio. Apart from micro-
albuminuria patient can present with fatigue, 
secondary hypertension and edema.  If further left 
untreated or if uncontrolled plasma sugar continues, 
the nephron further gets damaged and thus leading 
to irreversible changes of diabetic kidney disease.  
The study was screened in 90 diabetic 
patients and out of which 30 patients who were fit 
under the inclusion criteria was taken up for the 
study. The disease of Mootravaha srotas can be 
broadly classified into two categories with two 
different presentations. One group with less 
production of urine collectively called as Mutraghata 
and another group opposite to it and justified by the 
name Prameha. When the disease Prameha is left 
untreated then it is an open invitation for all the 
complications to occur. On long run the disease 
Prameha as a complication can lead to Mutraghata.  
There are studies were the efficacy of herbal 
drugs or herbomineral drugs on Prameha was carried 
out. On the contrary there were a few studies that 
were taken to evaluate the efficacy of herbal or 
herbomineral drug on Mutraghata. But this study is 
unique of its kind where the efficacy of the drug is 
evaluated in both Prameha and its complication as 
Basthi marma Abhigata which if left untreated will 
develop Mutraghata. The selection of drug was the 
important step in the study because the selected drug 
should not only act on plasma glucose but also should 
effectively act on renal parameters. Text says 
Shilajithu loha rasayana as one of the best drug that 
can combat both renal function as well as plasma 
glucose. So on this ground the study was conducted. 
The study included primary outcome measures and 
secondary outcome measures which included both 
diabetic parameters and renal parameters. Diabetic 
parameters include fasting blood sugar, glycosylated 
haemoglobin and symptoms of Prameha mentioned 
in classical text.  Cystatin-c, estimated glomerular 
filtration rate, urine albumin to creatinine ratio and 
systolic blood pressure are renal parameters. 
When the overall symptoms of Prameha were 
observed there was a remarkable positive change in 
all the symptoms of Prameha. Prameha is a disorder 
where there in the initial stage there will vitiation of 
Kapha and Medas further adding on the 10 body 
elements that gets lodged in Basthi producing 
Prameha in the form of excessive urination. Though 
Prameha is Medas vikara the disease seat is in Basthi 
which is seat of Mutra vaha srotas, as well as a Sadhya 
pranahara marma. So in turn along with the Medas 
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even urinary system gets hampered. This vitiated 
Mutra gives various associated illness which need 
aggressive care. On the long run this effects the 
Marma and produces set of symptoms like Shotha 
that are different from Prameha. On other hand 
diabetes is a condition with increased plasma glucose 
leading to damage of nephrons on the long run and is 
named as diabetic nephropathy or diabetic kidney 
disease where the symptoms are quite different from 
that of mother disease.  
 Reducing symptoms of Prameha like Prabhuta 
Avila mootrata, Kara pada daha, Dourbalya, 
Kshuda, Atitrishna. 
 Reducing the complication of Basthi marma 
abhighata in terms of Shotha. 
 On conventional system, reducing the plasma 
blood glucose. 
 Also reducing the symptoms of diabetic kidney 
disease and improving renal functions. 
Treating this type of condition might require 
many combinations of drugs. Where some drugs act 
on Mootravaha srotas and some drugs act on plasma 
glucose. There are very few formulations that acts on 
all the above said criteria. For a formulation to be 
stated as successful in Basthi marma abhigata in 
Prameha it should reduce the symptoms of Prameha, 
it should reduce the symptoms of Basthi marma 
Abhigata in Prameha and on contrary it should also 
reduce the plasma glucose and renal function. The 
combination that perfectly matches the indication is 
Shilajithu loha rasayana. In the study the drug proved 
to reduce the plasma glucose, increase the renal 
function by improving the glomerular filtration rate 
and reducing cystatin-c, also reducing the symptoms 
of Prameha thus proving the drug to be a drug of 
choice in Basthi marma abhigata in Prameha/diabetic 
nephropathy. 
CONCLUSION 
From the above data it proves that the drug 
Shilajithu loha rasayana that was selected for the 
study of affliction of Basthi marma in patients with 
Prameha proved very efficacious in reducing the 
plasma glucose level at the same time improving the 
renal function parameter with statistical evidence. 
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